Another Statin meta-analysis.

[pca2004]

New study [1].

"It is widely thought that statins have huge therapeutic potential against prostate cancer (PCA). This study aimed to investigate the effect of statin exposure on PCA incidence and prognosis. ...

"A total of 21 studies were included in this meta-analysis. The pooled estimates showed that exposure to hydrophilic statins was not associated with the incidence of PCA .., while the incidence of PCA was significantly decreased in populations exposed to lipophilic statins compared with the nonexposed group .., mainly in Western countries ...

"Subgroup analysis showed that simvastatin ... effectively reduced the incidence of PCA. The prognosis of PCA in patients exposed to both hydrophilic ... and lipophilic ... statins were better than in the nonexposed group, and this improvement was more significant in the East than in Western countries.

"This study demonstrates that statins can reduce the incidence of PCA and improve prognosis, and are affected by population region and statin properties (hydrophilic and lipophilic)."

-Patrick

[1] pubmed.ncbi.nlm.nih.gov/371...

[NPfisherman]

I think the efficacy of statins in PCa has had a number of articles proving value to our treatment. The question that I have, and everyone else should too is,"What role do the newer cholesterol drugs have for those of us with prostate cancer?"

I am talking about the PCSK9 drugs... and bempedoic acid..

frontiersin.org/articles/10...

I wrote about bempedoic acid some time back,but can no longer find it or other posts that I put up on APC... Go figure... what a surprise !!!

Don Pescado

[Papillon2]

👍